Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables. By leveraging the unique vaginal environment and integrating AI-powered analysis, we provide personalized, early, and accessible home health solutions that are accurate, affordable, and designed for early-stage detection. These solutions include rapid screening, monitoring, and therapeutic care for women’s health needs.
Tulipon our first device enables clean collection of vaginal secretions for cancer screening. Women of any age with abnormal bleeding, BRCA mutations, or high cancer risk can use Tulipon for up to 12 hours. Its liquid-lock mechanism preserves the sample, which is then sent to a lab for AI-powered liquid biopsy analysis. Tulipon minimizes human interference, preventing errors and contamination. Its absorbent-free design ensures access to all fluids and tissue secretions, empowering early detection, convenience, and proactive reproductive health diagnostics.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Gals Bio Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 16, 2022
www.haaretz.com
Israeli femtech firm hopes to revolutionize market with new smart tampon